Literature DB >> 23632185

Successful anticoagulation with fresh frozen plasma for cardiopulmonary bypass in a patient with heparin resistance: a cautionary tale.

Omar Badrin1, Suana Kushairi, Zuhrah Zakaria, Anand Sachithanandan.   

Abstract

Heparin resistance (HR) is an increasingly common occurrence due to a greater awareness of the benefits of antithrombosis prophylaxis in hospitalised patients with low molecular weight and unfractionated heparin. Furthermore as more high-risk patients with prior heparin exposure undergo cardiac surgery we can expect to encounter more such cases. Adequate anticoagulation is essential for the safe conduct of any operation requiring cardiopulmonary bypass and is usually achieved with systemic heparinisation. We report a case of successful anticoagulation with the intraoperative administration of fresh frozen plasma in a high-risk coronary patient with HR and highlight the perils of unwitting overheparinisation in such cases. This case highlights the importance of clinical awareness of this phenomenon and the available alternative anticoagulants.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23632185      PMCID: PMC3645014          DOI: 10.1136/bcr-2013-009112

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Does preoperative level of antithrombin III predict heparin resistance during extracorporeal circulation?

Authors:  José M Rodríguez-López; Esther del Barrio; Francisco S Lozano; Clemente Muriel
Journal:  Anesth Analg       Date:  2008-10       Impact factor: 5.108

2.  In vitro effect of fresh frozen plasma on the activated coagulation time in patients undergoing cardiopulmonary bypass.

Authors:  R E Barnette; R C Shupak; J Pontius; A K Rao
Journal:  Anesth Analg       Date:  1988-01       Impact factor: 5.108

3.  Predictors for heparin resistance in patients undergoing coronary artery bypass grafting.

Authors:  M Ranucci; G Isgrò; A Cazzaniga; G Soro; L Menicanti; A Frigiola
Journal:  Perfusion       Date:  1999-11       Impact factor: 1.972

4.  Fresh frozen plasma: a solution to heparin resistance during cardiopulmonary bypass.

Authors:  A H Sabbagh; G K Chung; P Shuttleworth; B J Applegate; W Gabrhel
Journal:  Ann Thorac Surg       Date:  1984-06       Impact factor: 4.330

5.  Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.

Authors:  A Michael Lincoff; John A Bittl; Robert A Harrington; Frederick Feit; Neal S Kleiman; J Daniel Jackman; Ian J Sarembock; David J Cohen; Douglas Spriggs; Ramin Ebrahimi; Gadi Keren; Jeffrey Carr; Eric A Cohen; Amadeo Betriu; Walter Desmet; Dean J Kereiakes; Wolfgang Rutsch; Robert G Wilcox; Pim J de Feyter; Alec Vahanian; Eric J Topol
Journal:  JAMA       Date:  2003-02-19       Impact factor: 56.272

6.  Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.

Authors:  Hilde Pleym; Vibeke Videm; Alexander Wahba; Arne Asberg; Tore Amundsen; Lise Bjella; Ola Dale; Roar Stenseth
Journal:  Eur J Cardiothorac Surg       Date:  2006-05-03       Impact factor: 4.191

7.  Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass.

Authors:  S C Nicholson; D M Keeling; M E Sinclair; R D Evans
Journal:  Br J Anaesth       Date:  2001-12       Impact factor: 9.166

Review 8.  Treating heparin resistance with antithrombin or fresh frozen plasma.

Authors:  Bruce D Spiess
Journal:  Ann Thorac Surg       Date:  2008-06       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.